ABL
Ana Daniels is currently the Senior Director Legal at ABL, an Institut Merieux Company, where Ana heads the legal department. Ana has prior experience as the Director of R&D Global Medical Risk Management at GSK, where Ana received recognition for their innovative work. Ana has also served as General Counsel at HR Pharmaceuticals, Inc. and Novavax, Inc., overseeing legal operations. Ana's legal expertise includes handling intellectual property agreements and complex commercial contracts. Ana has a diverse educational background, holding degrees in English Language and Literature, Chemistry, History of Art, and a Juris Doctor from American University Washington College of Law.
This person is not in any teams
This person is not in any offices
ABL
From development to market ABL Europe provides GMP viral vectors, contributing to the success of our clients’ immunotherapy innovations. ABL Europe SAS is a pure-play GMP CMO licensed in accordance with EMA, completely dedicated to the provision of viral vector GMP contract manufacturing services, and a subsidiary of ABL Inc. under the corporate ownership of Institut Mérieux. ABL has a strong technical & regulatory track record in process development, scale-up & GMP manufacturing of filterable & non-sterile filterable (aseptic processing) viral vectors used in all phases of clinical development globally. With different adherent platforms (< 60 m2) and suspension (< 500 L) capabilities for drug substance and drug product (< 10,000 vials per batch) in-house, experience in process characterisation and validation, ABL provides its clients with a long-term strategic manufacturing option through clinical development & licensure for a range of virus vector gene therapy & vaccine products. ABL Europe’s clients are located worldwide.